Steven L. Shafer
Corporate Officer/Principal bij Stanford University
Profiel
Steven L.
Shafer was the founder of Signature Therapeutics, Inc. founded in 2004, where he held the title of Head-Medical Affairs.
Currently, he holds the position of Professor at both Stanford University and The University of California, San Francisco.
Dr. Shafer's education includes a doctorate from Stanford University and an undergraduate degree from Princeton University.
Actieve functies van Steven L. Shafer
| Bedrijven | Functie | Begin |
|---|---|---|
| Stanford University | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Eerdere bekende functies van Steven L. Shafer
| Bedrijven | Functie | Einde |
|---|---|---|
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Oprichter | - |
Opleiding van Steven L. Shafer
| Stanford University | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Health Technology |